Center for Innovative Drug Discovery

Therapeutic Approaches: Small Molecules

Therapeutic Areas of Expertise: Infectious Diseases, Neurological Disorders, Oncology, Psychiatric Disorders, Regenerative Medicine

Center/Program Highlights: The Center for Innovation in Drug Discovery (CIDD), a joint venture between The University of Texas at San Antonio and The University of Texas Health Science Center, is composed of two facilities: a High-Throughput Screening (HTS) Facility located at UTHSCSA and a Medicinal Chemistry and Synthesis Core Facility at UTSA. The ultimate intent of the CIDD is to provide a diverse array of core facilities and expertise to facilitate the translation of basic scientific discoveries into tangible pre-clinical candidate drugs that can be further developed into clinical therapies for human disease. The collaborative research strategy within the CIDD has been enormously successful, establishing a 35% success rate in extramural collaborative grant funding to date.

Sources of Funding: Federal/State, Philanthropy, University, Revenue


Institutional Affiliation(s): University of Texas San Antonio, University of Texas Health Science Center San Antonio

One UTSA Circle
San Antonio
Texas, 78249
United States

Center/Program Start Date: 2012

Number of Employees: 9